Sarepta Therapeutics, Inc. SRPT Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s increase (decrease) in other operating assets?
- Sarepta Therapeutics, Inc. (SRPT) reported increase (decrease) in other operating assets of $14.55M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s increase (decrease) in other operating assets decreased by 3.5% year-over-year, from $15.07M to $14.55M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s increase (decrease) in other operating assets?
- Over 2 years (2021 to 2023), Sarepta Therapeutics, Inc.'s increase (decrease) in other operating assets has grown at a -86.8% compound annual growth rate (CAGR), from -$103.2M to -$1.81M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.